Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma
Michael T. Tetzlaff, Penvadee Pattanaprichakul, Jennifer A. Wargo, et al.
Human Pathology (2015) Vol. 46, Iss. 8, pp. 1101-1110
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson, Juliann Shih, Christina Yau, et al.
Cancer Cell (2017) Vol. 32, Iss. 2, pp. 204-220.e15
Open Access | Times Cited: 765
Managing Metastatic Melanoma in 2022: A Clinical Review
Benjamin Switzer, Igor Puzanov, Joseph J. Skitzki, et al.
JCO Oncology Practice (2022) Vol. 18, Iss. 5, pp. 335-351
Open Access | Times Cited: 147
Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection
Narittee Sukswai, Joseph D. Khoury
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 5, pp. 368-375
Closed Access | Times Cited: 71
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
Irene Vanni, Enrica T. Tanda, Francesco Spagnolo, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 59
Comparative efficiency of differential diagnostic methods for the identification of BRAF V600E gene mutation in papillary thyroid cancer (Review)
Qian Liu, Xue Jiang, Wenling Tu, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 5
Updates in Therapy for Advanced Melanoma
Bhavana Singh, April K.S. Salama
Cancers (2016) Vol. 8, Iss. 1, pp. 17-17
Open Access | Times Cited: 45
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry
William Bruno, Claudia Martinuzzi, Virginia Andreotti, et al.
Oncotarget (2016) Vol. 8, Iss. 5, pp. 8069-8082
Open Access | Times Cited: 42
Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical Pathologist
Pari Jafari, Megan Forrest, Jeremy P. Segal, et al.
Modern Pathology (2025), pp. 100752-100752
Closed Access
Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing
Jeannelyn S. Estrella, Michael T. Tetzlaff, Roland L. Bassett, et al.
Molecular Cancer Therapeutics (2015) Vol. 14, Iss. 12, pp. 2887-2895
Open Access | Times Cited: 40
Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma
Takuya Furuta, Hiroaki Miyoshi, Satoru Komaki, et al.
Neuropathology (2018) Vol. 38, Iss. 3, pp. 218-227
Open Access | Times Cited: 37
Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma
Carlos A. Torres‐Cabala, Elsa M. Li-Ning-Tapia, Wen-Jen Hwu
Archives of Medical Research (2020) Vol. 51, Iss. 8, pp. 827-838
Closed Access | Times Cited: 28
Tissue Multiplex Analyte Detection in Anatomic Pathology – Pathways to Clinical Implementation
Keith A. Wharton, Douglas Wood, Maël Manesse, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 27
Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research
Alina Bollhagen, Bernd Bodenmiller
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2071-2088
Open Access | Times Cited: 3
High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens
Lauren Y. Cheng, Lauren E. Haydu, Ping Song, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype
Cristina Pellegrini, Lucia Di Nardo, Gianluca Cipolloni, et al.
Journal of Molecular Diagnostics (2017) Vol. 20, Iss. 1, pp. 110-122
Open Access | Times Cited: 22
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Wenxian Wang, Bin Lian, Chunwei Xu, et al.
The Innovation (2024) Vol. 5, Iss. 6, pp. 100661-100661
Open Access | Times Cited: 2
BRAF inhibitor therapy–associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression
Kumaran Mudaliar, Michael T. Tetzlaff, Madeleine Duvic, et al.
Human Pathology (2015) Vol. 50, pp. 79-89
Closed Access | Times Cited: 19
Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay
Audrey Vallée, Marie Denis-Musquer, Guillaume Herbreteau, et al.
PLoS ONE (2019) Vol. 14, Iss. 8, pp. e0221123-e0221123
Open Access | Times Cited: 18
BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods
Odharnaith O’Brien, Tomás G. Lyons, Sandra Murphy, et al.
Journal of Clinical Pathology (2017) Vol. 70, Iss. 11, pp. 935-940
Closed Access | Times Cited: 17
Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry
Priyadharsini Nagarajan, Michael T. Tetzlaff, Johnathan L. Curry, et al.
Actas Dermo-Sifiliográficas (2016) Vol. 108, Iss. 1, pp. 17-30
Closed Access | Times Cited: 14
Characteristics of Metastatic and Nonmetastatic Pulmonary Sclerosing Pneumocytomas: A Clinicopathological Study of 68 Cases and 15 Reported Metastatic Cases
Xingen Wang, C.S. Ng, Xiaoxin Shi, et al.
Laboratory Investigation (2023) Vol. 103, Iss. 7, pp. 100135-100135
Open Access | Times Cited: 4
Cytomorphology of metastatic colonic MXD4::NUTM1‐rearranged sarcoma
Zachary Alan Wilkinson, Maria Luisa Policarpio‐Nicolas
Diagnostic Cytopathology (2024) Vol. 52, Iss. 6, pp. 342-349
Open Access | Times Cited: 1
The Potential Utility of RAS Q61R Immunohistochemistry as a Screening Tool in Pre-operative Fine Needle Aspirates of Medullary Thyroid Carcinoma
Brea Deyette, Daniel Lubin, Aswathy M. Cheriyan, et al.
Endocrine Pathology (2024) Vol. 35, Iss. 4, pp. 385-396
Closed Access | Times Cited: 1
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
William Bruno, Claudia Martinuzzi, Bruna Dalmasso, et al.
Oncotarget (2017) Vol. 9, Iss. 5, pp. 5691-5702
Open Access | Times Cited: 12
Concordance in BRAF V600E status over time in malignant melanoma and corresponding metastases
Line B Nielsen, Nina Dabrosin, Karen Sloth, et al.
Histopathology (2017) Vol. 72, Iss. 5, pp. 814-825
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top